Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Wen Jie Chin
Observed names:
Chin, Wen Jie,
Wenjie Chin
Institution:
Hummingbird Scientific (United States)
Observed institutions:
Agency for Science, Technology and Research,
Nanyang Technological University,
Singapore Immunology Network,
Hummingbird Scientific (United States)
ORCID:
0000-0002-4604-1858
Observed ORCID:
0000-0002-4604-1858
OpenAlex ID:
A5061944184
Effective in vivo therapeutic IgG antibody against VP3 of enterovirus 71 with receptor-competing activity
2017
·
Qiang Jia
, Qingyong Ng
, et al.
·
Scientific Reports
·
28
PDF
Enhancing Antigen Cross-Presentation in Human Monocyte-Derived Dendritic Cells by Recruiting the Intracellular Fc Receptor TRIM21
2019
·
Patricia M L Ng
, Nivashini Kaliaperumal
, et al.
·
The Journal of Immunology
·
22
Selective targeting of pathogenic auto-reactive VH4–34 B cells with a rationally developed anti-VH4–34 antibody offers a new therapeutic approach for autoimmune disorders
2023
·
Shalini Paliwal
, Dipti Thakkar
, et al.
·
The Journal of Immunology
·
4
PDF
Abstract 2660: HMBD-501 - a novel Fc engineered, exatecan-based next generation HER3 targeting antibody drug conjugate shows robust efficacy and tolerability in pre-clinical solid tumor models
2023
·
Suhail Ahmed Kabeer Rasheed
, Dipti Thakkar
, et al.
·
Cancer Research
·
2
LSO-006 Targeting pathogenic auto-reactive VH4-34 B cells with a rationally developed and highly specific anti-VH4-34 antibody offers a new therapeutic approach for VH4-34 autoimmune disorders
2023
·
Shalini Paliwal
, Dipti Thakkar
, et al.
·
Lupus Science & Medicine
PDF
Functional and mechanistic studies on engineered antibodies that engage TRIM21
2020
·
Chin, Wen Jie
·
DR-NTU (Nanyang Technological University)
PDF
Show more works
View as search
Works count:
6
Citation count:
56
H-index:
3
I10-index:
2
Year
Topic
Type